Adaptin Bio, Inc.
APTN
$6.20
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.15M | -1.37M | -1.68M | -1.52M | -603.10K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 53.70K |
| Total Other Non-Cash Items | 345.40K | 176.70K | 320.10K | 250.00K | -320.00K |
| Change in Net Operating Assets | 204.40K | 488.40K | 583.10K | 248.10K | -1.41M |
| Cash from Operations | -596.30K | -702.90K | -772.40K | -1.02M | -2.28M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -92.40K | 0.00 | 0.00 | 0.00 | -275.00K |
| Issuance of Common Stock | 652.00K | 1.00M | 0.00 | 0.00 | 6.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -121.20K | -417.00K | 0.00 | 0.00 | -1.27M |
| Cash from Financing | 438.40K | 583.00K | 0.00 | 0.00 | 4.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.90K | -119.90K | -772.40K | -1.02M | 2.34M |